| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | — | — | — | — | $0.1B | $0.1B | $0.1B |
| Cost of Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Gross Profit | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.0B | $-0.0B | $-0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Net Income | $-0.0B | $-0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $-0.30 | $-0.37 | $0.01 | $1.05 | $1.53 | $1.29 | $1.84 | $1.83 |
| EPS (Diluted) | $-0.30 | $-0.37 | $0.01 | $0.30 | $0.34 | $0.35 | $0.32 | $0.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Current Assets | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Current Liabilities | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Stockholders' Equity | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |